Advertisement
Advertisement

CAPS

C

Capstone Holding Corp. Common Stock

3.26
USD
-0.06
-1.78%
Mar 10, 14:52 UTC -5
Closed
exchange

After-Market

2.874

-0.39
-11.87%

Capstone Holding Corp. Common Stock Profile

About

Capstone Therapeutics Corp., formerly known as OrthoLogic Corp., is a biotechnology company focused on developing a pipeline of novel therapeutic peptides aimed at helping patients with under-served medical conditions. The Company is engaged in the development and commercialization of two product platforms: AZX100 and Chrysalin. AZX100 is a novel synthetic 24-amino acid peptide, a class of compounds in the field of smooth muscle relaxation and fibrosis. AZX100 is currently being evaluated for commercially significant medical applications such as the treatment of pulmonary fibrosis, the prevention of hypertrophic and keloid scarring and intimal hyperplasia. Chrysalin, the Company's novel synthetic 23-amino acid peptide, stimulates cellular events leading to angiogenesis, revascularization, and repair of dermal and musculoskeletal tissues. It is currently being evaluated in disorders that involve vascular endothelial dysfunction. Capstone Therapeutics Corp. is headquartered in Tempe, Arizona.

Info & Links

CEO

--

Headquarters

--

Sector

Medical

Website

--

Auditor

--

Share holders

--

Employees

--

Capstone Holding Corp. Common Stock Statistics

Valuation Measures

Market Capitalization2

452.97K

Enterprise Value

2.79M

Enterprise Value/EBITDA(ttm)

-2.06

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

401.02%

Return on Assets(ttm)

--

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-1.35M

Net Income Available to Common(ttm)

-1.52M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

-0.64

52-Week Change

--

S&P 500 52-Week Change

9.70%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

90.00K

% Held by Insiders

42.80%

% Held by Institutions

2.55%

Balance Sheet

Total Cash(mrq)

--

Total Cash Per Share(mrq)

--

Total Debt(mrq)

--

Total Debt/Equity(mrq)

-95.80%

Current Ratio(mrq)

0.86%

Quick Ratio(mrq)

--

Book Value Per Share(mrq)

-50.75

Cash Flow

Operating Cash Flow Per Share(ytd)

-19.97

Free Cash Flow(ytd)

-1.09M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement